Gogo Inc. filed a current report on November 6, 2026, disclosing that it and its wholly owned subsidiary Gogo Intermediate Holdings LLC entered into a third amendment to their 2021 credit agreement, converting a portion of existing term loans into new 2026 Extended Term …
Medicus Pharma Ltd. filed a Form 425 on November 6, 2026, disclosing third-quarter 2026 financial results, a co-development and license agreement with Pfizer for CD228V, a non-binding letter of intent for a proposed SkinJect SPAC business combination at approximately $135 million pre-money enterprise valuation, …
GPGI, Inc. (NYSE:GPGI) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing 289,901,892 shares of Class A common stock outstanding as of November 5, 2026.
BancFirst Corporation filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the period ended September 30, 2026, and reporting results for both the third quarter and the first nine months of the fiscal year.
abrdn Gold ETF Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026, reporting financial results and portfolio data for the three and nine months ended September 30, 2026.
Essent Group Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission, disclosing financial statements and related information for the third quarter of fiscal year 2026.
Telomir Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 6, 2026, covering the fiscal quarter ended September 30, 2026.
Blackstone Real Estate Income Trust, Inc. filed its Form 10-Q with the SEC on November 6, 2026, covering the quarterly period ended September 30, 2026, disclosing a net loss of $296.1 million for the third quarter and $1.147 billion for the nine months ended …
Chiron Real Estate Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 6, 2026, reporting a net loss of $5.7 million for the third quarter and net income of $68.2 million for the nine months …
Creative Medical Technology Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting a net loss attributable to the company of $5,587,129 for the nine months ended September 30, 2026.